Tejara Capital LTD has filed its 13F form on February 10, 2025 for Q4 2024 where it was disclosed a total value porftolio of $153 Billion distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcutis Biotherapeutics, Inc. with a value of $12.4B, Roivant Sciences Ltd. with a value of $9.62B, Borr Drilling LTD with a value of $8.42B, Nov Inc. with a value of $8.35B, and Mereo Biopharma Group PLC with a value of $8.11B.

Examining the 13F form we can see an decrease of $57.2B in the current position value, from $210B to 153B.

Tejara Capital LTD is based out at London, X0

Below you can find more details about Tejara Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $153 Billion
Energy: $69 Billion
Healthcare: $53.1 Billion
Technology: $14.5 Billion
Communication Services: $2.96 Billion
Consumer Cyclical: $2 Billion
Utilities: $1.79 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $153 Billion
  • Prior Value $210 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 10, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 18 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.